To fight the ever-growing threat from antibiotic-resistant bacteria, Australian researchers developed a therapy containing a repurposed experimental Alzheimer's drug, successfully killing some of the most difficult to treat superbugs.

More than 75 percent of people with mental, neurological and substance use disorders receive no treatment for their condition at all in low- and middle-income countries (MICs), global organisations say.